Value through Innovation27 July 2016

Clinical Study Results

  • Ritobegron - Spinal Cord Injuries
    Clinical Study Number 1207.4
    Study Indication Spinal Cord Injuries
    Product Ritobegron
    Generic Name Ritobegron
    Lab Code
    Clinical Phase I
    Study Title

    A phase I, randomised, double-blind, placebo-controlled study to determine pharmacodynamic effects and pharmacokinetics of a single oral dose of 320 mg KUC-7483 CL in patients with spinal cord injury and neurogenic detrusor overactivity

    Study Document Trial synopsis 1207.4 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.